KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biogen (BIIB) Treasury Shares (2016 - 2026)

Biogen has reported Treasury Shares over the past 18 years, most recently at $3.0 billion for Q1 2026.

  • For Q1 2026, Treasury Shares changed 0.0% year-over-year to $3.0 billion; the TTM value through Mar 2026 reached $3.0 billion, changed 0.0%, while the annual FY2025 figure was $3.0 billion, 0.0% changed from the prior year.
  • Treasury Shares for Q1 2026 was -$23.8 million at Biogen, roughly flat from -$23.8 million in the prior quarter.
  • Over five years, Treasury Shares peaked at $23.8 million in Q4 2022 and troughed at -$23.8 million in Q1 2022.
  • A 5-year average of -$14.0 million and a median of -$23.8 million in 2022 define the central range for Treasury Shares.
  • On a YoY basis, Treasury Shares climbed as much as 0.0% in 2022 and fell as far as 0.0% in 2022.
  • Year by year, Treasury Shares stood at $3.0 billion in 2022, then changed by 0.0% to $3.0 billion in 2023, then changed by 0.0% to $3.0 billion in 2024, then changed by 0.0% to $3.0 billion in 2025, then changed by 0.0% to $3.0 billion in 2026.
  • Business Quant data shows Treasury Shares for BIIB at $3.0 billion in Q1 2026, $3.0 billion in Q4 2025, and $3.0 billion in Q3 2025.